Page last updated: 2024-10-24

slow axonal transport

Definition

Target type: biologicalprocess

The directed slow movement of non-membranous molecules in nerve cell axons. It is comprised of a Slow Component a (SCa) and a Slow Component b (SCb) which differ in transport rates and protein composition. [PMID:6378920]

Slow axonal transport, also known as axoplasmic transport, is a fundamental process responsible for the movement of essential components along the length of axons, the long projections of neurons that transmit signals throughout the nervous system. Unlike fast axonal transport, which primarily moves membrane-bound organelles and vesicles, slow axonal transport is characterized by its significantly slower rate, transporting a diverse array of proteins, cytoskeletal components, and enzymes. This process is crucial for maintaining the structural integrity, functional capacity, and overall health of axons.

Slow axonal transport is typically divided into two distinct phases:

1. **Slow Component a (SCa):** This phase moves at a rate of approximately 0.2-1 mm per day and primarily carries cytoskeletal proteins, including microtubules, actin filaments, and neurofilaments. These proteins are essential for maintaining the structural integrity and stability of the axon, providing a scaffold for other molecules and enabling the efficient transmission of nerve impulses.

2. **Slow Component b (SCb):** This phase moves at a slightly faster rate of 1-4 mm per day and transports a wider range of proteins, including enzymes involved in various metabolic processes, such as glycolysis and protein synthesis. These enzymes are essential for sustaining the energy requirements and biochemical functions of the axon.

The mechanism of slow axonal transport is still not fully understood, but it is believed to involve a complex interplay of motor proteins, cytoskeletal elements, and signaling pathways. Unlike fast axonal transport, which relies on motor proteins like kinesin and dynein to move along microtubules, slow axonal transport likely involves a more passive process, possibly driven by the polymerization and depolymerization of cytoskeletal elements.

Several factors can influence the rate and efficiency of slow axonal transport, including:

- **Age:** As neurons age, the rate of slow axonal transport can decline, potentially contributing to age-related neuronal dysfunction.
- **Metabolic state:** Changes in energy levels, such as those associated with diabetes, can impair slow axonal transport.
- **Environmental factors:** Exposure to toxins or other stressors can negatively impact the transport process.

Disruptions in slow axonal transport can lead to a variety of neurological disorders, including:

- **Axonal degeneration:** Damage to axons can result from impaired transport of essential components, leading to neuronal dysfunction and loss.
- **Neurodevelopmental disorders:** Dysregulation of slow axonal transport during early development can contribute to neurological disorders such as autism and intellectual disability.
- **Neurodegenerative diseases:** Slow axonal transport is often compromised in neurodegenerative diseases like Alzheimer's disease and Parkinson's disease, contributing to neuronal dysfunction and progressive neurodegeneration.

Therefore, understanding the intricacies of slow axonal transport is critical for developing therapeutic strategies for a wide range of neurological disorders. Future research efforts aimed at elucidating the molecular mechanisms and regulatory pathways of this essential process hold immense promise for improving the lives of individuals affected by neurological diseases.'
"

Proteins (1)

ProteinDefinitionTaxonomy
Heat shock cognate 71 kDa proteinA heat shock cognate 71 kDa protein that is encoded in the genome of human. [PRO:DAN]Homo sapiens (human)

Compounds (9)

CompoundDefinitionClassesRoles
adenosine diphosphateAdenosine Diphosphate: Adenosine 5'-(trihydrogen diphosphate). An adenine nucleotide containing two phosphate groups esterified to the sugar moiety at the 5'-position.adenosine 5'-phosphate;
purine ribonucleoside 5'-diphosphate
fundamental metabolite;
human metabolite
tubercidintubercidin : An N-glycosylpyrrolopyrimidine that is adenosine in which the in the 5-membered ring that is not attached to the ribose moiety is replaced by a carbon. Tubercidin is produced in the culture broth of Streptomyces tubericidus.

Tubercidin: An antibiotic purine ribonucleoside that readily substitutes for adenosine in the biological system, but its incorporation into DNA and RNA has an inhibitory effect on the metabolism of these nucleic acids.
antibiotic antifungal agent;
N-glycosylpyrrolopyrimidine;
ribonucleoside
antimetabolite;
antineoplastic agent;
bacterial metabolite
toyocamycintoyocamycin : An N-glycosylpyrrolopyrimidine that is tubercidin in which the hydrogen at position 5 of the pyrrolopyrimidine moiety has been replaced by a cyano group.

Toyocamycin: 4-Amino-5-cyano-7-(D-ribofuranosyl)-7H- pyrrolo(2,3-d)pyrimidine. Antibiotic antimetabolite isolated from Streptomyces toyocaensis cultures. It is an analog of adenosine, blocks RNA synthesis and ribosome function, and is used mainly as a tool in biochemistry.
antibiotic antifungal agent;
N-glycosylpyrrolopyrimidine;
nitrile;
ribonucleoside
antimetabolite;
antineoplastic agent;
apoptosis inducer;
bacterial metabolite
nsc 65346sangivamycin : A nucleoside analogue that is adenosine in which the nitrogen at position 7 is replaced by a carbamoyl-substituted carbon. It is a potent inhibitor of protein kinase C.

sangivamycin: RN given refers to parent cpd
nucleoside analogueprotein kinase inhibitor
adenosinequinquefolan B: isolated from roots of Panax quinquefolium L.; RN not in Chemline 10/87; RN from Toxlitadenosines;
purines D-ribonucleoside
analgesic;
anti-arrhythmia drug;
fundamental metabolite;
human metabolite;
vasodilator agent
8-aminoadenosine
5'-deoxyadenosine5'-deoxyadenosine : A 5'-deoxyribonucleoside compound having adenosine as the nucleobase.

5'-deoxyadenosine: main heading DEOXYADENOSINE refers to the 3' cpd
5'-deoxyribonucleoside;
adenosines
Escherichia coli metabolite;
human metabolite;
mouse metabolite
ver 155008VER 155008: structure in first sourcepurine nucleoside
nms-e973NMS-E973: structure in first source